Erratum: Emerging Immunological Pathways in SLE: Immune Trafficking and S1PR1 Modulation as Therapeutic Strategies - European Medical Journal

This site is intended for healthcare professionals

Erratum: Emerging Immunological Pathways in SLE: Immune Trafficking and S1PR1 Modulation as Therapeutic Strategies

Author: EMJ

Citation: EMJ. 2026; https://doi.org/10.33590/emj/87XBB6KI

Date correction published: 16/03/2026

Original publication¹

In the ICA1 published on the EMJ website on 5th March 2026, an error was identified in Figure 2.

In the figure, Gai, Gaq, Gas, TNF-a, and NF-kB have all incorrectly used letters from the Roman alphabet instead of the Greek symbols α and κ.

Figure 2 has now been updated to ensure that the letter ‘a’ in Gai, Gas, Gaq, and TNF-a has been changed to ‘α’, so they now read as Gαi, Gαs, Gαq, and TNF-α.

Figure 2 has also been updated to ensure that the letter ‘k’ in NF-kB has been changed to ‘κ’, so it now reads as NF-κB.

EMJ apologises for the error and any inconvenience caused.

Reference:

1. Askanase AD et al. Emerging immunological pathways in SLE: immune trafficking and S1PR1 modulation as therapeutic strategies. EMJ. 2026;11[1]:50-61.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.